Pathology of Genetically Engineered and Other Mutant Mice. Группа авторов

Чтение книги онлайн.

Читать онлайн книгу Pathology of Genetically Engineered and Other Mutant Mice - Группа авторов страница 55

Pathology of Genetically Engineered and Other Mutant Mice - Группа авторов

Скачать книгу

GD6.0–7.5 Early organogenesis GD8.0–10.5 Cardiovascular or central nervous system defects, abnormal erythropoiesis Mid‐gestational death due to cardiovascular or hematopoietic insufficiency GD10.0–13.0 Late organogenesis GD11.0–15.0 Defects in many organs, abnormal erythropoiesis, delayed growth Mid‐ to late‐gestational death due to cardiovascular or hematopoietic insufficiency GD13.0–16.0 Near‐term growth spurt GD15.5–18.5 Altered cardiovascular function, abnormal erythropoiesis, delayed growth Late‐gestational or perinatal death due to cardiovascular or hematopoietic insufficiency (or edema or hemorrhage) GD16.0 to PND0.5 Early neonatal PND0 Abnormal cardiovascular, central nervous system, cutaneous, musculoskeletal, or pulmonary function Insufficiencies in circulation or respiration (inability to breath) PND0–0.5 Late neonatal PND0.5–2.0 Abnormal cardiovascular, gastrointestinal, metabolic, or neural functions Insufficiencies in digestion or suckling (inability to feed) PND1.0–2.5 Juvenile PND2.5–28 Abnormal hematopoietic, immune, metabolic, or renal functions Sustained anemia, abnormal immune function, metabolic or renal insufficiencies PND3.0–28

      GD = gestational day (where GD0 is the vaginal plug‐positive day), PND = postnatal day.

      Source: Szaba et al. [83] by permission of the Authors under a Creative Commons 4.0 International License.

Photo depicts developmental phenotypes resulting from circulatory disturbances may present as macroscopic or microscopic lesions.

      Source: Tullio et al [98] with permission of the U.S. National Academy of Sciences.

Скачать книгу